PERP_B: Strong sales growth from ES-Medical offset by negative operating result and strategic realignment

About this update from Perpetua Medical Ab Class B

Net sales rose 135% year-over-year to 3,227 KSEK, driven by the ES-Medical acquisition, but operating profit turned negative due to one-off costs and business transitions. Acquisition strategy remains unchanged, with ongoing efforts to divest Wastelog. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Perpetua Medical Ab Class B